Drug intelligence / Profile preview

VL-NL-02

Development stage: Unknown
Administration: Oral

Overview

VL-NL-02 is a dietary supplement under investigation for its potential to improve sleep quality, including restorative sleep, mood, stress levels, and sleep stages. It is being evaluated in a randomized, double-blind, placebo-controlled clinical trial with endpoints measuring sleep quality (Insomnia Severity Index), mood (Brief Mood Introspection Scale), dream and sleep emotions (DSEA Questionnaire), restorative sleep (Restorative Sleep Questionnaire - Weekly Version), quality of life (RAND SF-36), and sleep architecture (polysomnography). The specific formulation, mechanism of action, and active ingredients have not been disclosed in the available sources, but it is classified as a dietary supplement, not a pharmaceutical drug[1][3].

Brand names: VL-NL-02VL-NL02VL-NL 02
Other names: VL-NL-02VL-NL02VL-NL 02

Beyond the preview

Go deeper on VL-NL-02.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VL-NL-02.

Explore the full profile